Saturday 17 October 2026 Export ZEPP’s income statement to Excel — free account

Zepp Health Corporation Sponsored ADR

Zepp Health Corporation Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $258.9 million, up 41.8% from fiscal 2024. In the quarter to June 2026, revenue grew 6.93%, EPS fell 46.9%, free cash flow fell 103.7% and total debt rose 26.4%, each against the same quarter a year earlier.

3.04 0.16 −5.00%

Follow ZEPP

Alert me

Market cap: $27.1M
P/E: 0.0×
Fwd P/E: 619×
Dividend yield: —
F-score: 5/9
Altman Z: 1.01
Beneish M: −2.49
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 0.09

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	1	—	—	1	—

Insider Ownership 46.51%

Capital & Financial Ratios $m

Market Cap 27.14

Revenue 276.03

Net Income (40.07)

Free Cash Flow (11.76)

Net Debt 26.97

Current Ratio 0.90

Debt/Equity 0.72

P/E ratio 0.00

Fwd P/E 619.00

P/S ratio 0.17

P/B ratio 0.26

Past 5Y EPS Growth —

This Y EPS Growth 16.67%

Next Y EPS Growth 60.00%

Next Y revenue growth 687.96%

Next 5Y EPS Growth 8.71%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 20.67%

10-year low 10-year high

P/B against its own 10 years 29.54%

10-year low 10-year high

EV/Sales against its own 10 years 26.85%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	0.00	0.40
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	146	112	113	106
Receivables	69	66	74	83
Inventory	85	57	73	62
Other	—	—	—	—
	317	252	294	283

	2023	2024	2025	Q'26
Payables	37	51	81	88
ST’ Debt	2	42	56	77
Other	0	0	0	0
	155	195	287	314

Compound Annual Growth %

	10y	5y	3y
Sales	—	(23.47%)	(24.46%)
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	(12.51%)	(18.01%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	52	64	—	—	—
’25	39	59	76	85	259
’24	40	41	42	60	183
’23	94	92	83	83	353
’22	119	165	170	146	601
’21	175	284	249	260	981
’20	154	161	329	342	986

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	(26)	(26)
’24	—	—	—	(24)	(24)
’23	—	—	—	—	43
’22	—	—	—	—	(114)
’21	—	—	—	—	(36)
’20	—	—	—	—	24

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	(26)	(26)
’24	—	—	—	(25)	(24)
’23	—	—	—	0	46
’22	—	—	—	(1)	(116)
’21	—	—	—	—	(44)
’20	—	—	—	(13)	11

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(1.24)	(0.72)	—	—	—
’25	(1.23)	(0.49)	(0.10)	(0.69)	(2.52)
’24	(0.92)	(0.68)	(0.82)	(2.29)	(4.68)
’23	(1.28)	(0.64)	0.02	(0.08)	(1.96)
’22	(0.88)	(1.04)	(0.16)	(0.72)	(2.72)
’21	(0.40)	0.88	0.44	0.09	1.32
’20	0.16	0.12	0.72	1.08	2.16

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	33.72	29.08	35.00	17.04	4.20	3.86	2.06	2.13	Analyst estimates 2026–2028 Powerpack
	High	—	—	60.36	78.64	72.82	81.00	21.56	8.76	8.40	61.85
People
People	Employees	376	416	694	1,132	1,507	1,227	987	839	765	763
	Revenue/emp, $m	0.62	0.76	0.76	0.74	0.65	0.80	0.61	0.42	0.24	0.34
Income, $m
Income, $m	Revenue	234	315	530	835	986	981	601	353	183	259
	Gross margin, %	17.74	24.14	25.77	25.25	20.71	20.89	19.39	26.17	38.46	38.31
	EBT	4	29	56	94	41	17	(54)	(35)	(58)	(35)
	EBT margin, %	1.85	9.37	10.61	11.22	4.13	1.71	(8.99)	(9.81)	(31.71)	(13.70)
	Net income	4	26	49	82	35	21	(42)	(31)	(76)	(40)
	Depreciation	0	1	1	2	4	8	8	8	5	5
Per share, $
Per share, $	Revenue	67.31	74.34	40.04	54.83	63.49	62.23	39.02	23.22	11.29	16.28
	Earnings	1.04	1.68	3.48	5.40	2.24	1.36	(2.72)	(1.96)	(4.68)	(2.52)
	Cash flow	0.75	8.65	7.77	4.04	1.55	(2.31)	(7.42)	2.80	(1.51)	(1.62)
	Capex	(0.50)	(0.78)	(0.76)	(0.43)	(0.84)	(0.50)	(0.09)	0.20	0.02	(0.01)
	Free cash flow	0.25	7.87	7.01	3.60	0.72	(2.82)	(7.51)	3.00	(1.49)	(1.63)
	Book value	1.30	8.28	19.88	23.56	26.94	29.21	25.29	23.21	15.62	13.49
	Shares, m	3	4	13	15	16	16	15	15	16	16
Valuation, ×
Valuation, ×	P/E	0.00	0.13	11.54	8.97	21.94	19.80	0.00	0.00	0.00	0.00
	P/S	0.00	0.00	0.98	0.88	0.75	1.32	0.16	0.25	0.23	1.65
	P/B	0.00	0.02	1.98	2.04	1.76	2.79	0.25	0.25	0.17	2.00
	EV/Sales	0.00	0.00	0.54	0.58	0.48	1.28	0.32	0.18	0.26	1.66
	EV/FCF	0.00	0.00	2.14	2.56	3.10	8.17	4.52	(15.95)	12.75	(36.61)
Cash, $m
Cash, $m	Operating cash flow	3	37	103	61	24	(36)	(114)	43	(24)	(26)
	Capex	(2)	(3)	(10)	(7)	(13)	(8)	(1)	3	0	0
	Free cash flow	1	33	93	55	11	(44)	(116)	46	(24)	(26)
Balance, $m
Balance, $m	Working capital	34	64	214	274	312	279	187	162	56	7
	Total debt	2	6	6	16	94	201	245	122	117	115
	Net debt	(23)	(53)	(227)	(246)	(259)	(40)	99	(24)	5	2
	Shareholders’ equity	5	35	263	359	418	460	389	353	253	215
Returns, %
Returns, %	ROA	(0.98)	3.82	4.72	13.52	4.25	2.33	(4.86)	(4.43)	(13.01)	(7.33)
	ROIC	0.00	0.00	91.68	48.12	10.44	2.19	(7.62)	(5.79)	(11.44)	(8.43)
	ROE	(9.29)	35.79	11.07	26.46	9.02	4.92	(9.84)	(8.36)	(25.02)	(17.15)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
GPRO GoPro, Inc.	$215.2M	— (loss-making)	— (loss-making)	−31.26% (below 0%: shrinking)	n/m	−242.66% (below 0%: shrinking)	30.17%	(37.15%)	Compare
VUZI Vuzix Corporation	$182.3M	— (loss-making)	— (loss-making)	−14.06% (below 0%: shrinking)	n/m	−23.09% (below 0%: shrinking)	(57.96%)	(696.34%)	Compare
UEIC Universal Electronics Inc.	$66.7M	— (loss-making)	— (loss-making)	−25.01% (below 0%: shrinking)	n/m	−22.84% (below 0%: shrinking)	35.37%	6.54%	Compare
AXIL AXIL Brands, Inc.	$37.5M	13.7×	—	−11.17% (below 0%: shrinking)	+20.00% (above 0%: growing)	+531.52% (above 0%: growing)	82.62%	7.18%	Compare
KOSS Koss Corporation	$35.4M	— (loss-making)	53.5×	+5.83% (above 0%: growing)	n/m	+288.26% (above 0%: growing)	60.98%	8.19%	Compare
ZEPP Zepp Health Corporation Sponsored ADR	$27.1M	— (loss-making)	619×	+6.93% (above 0%: growing)	n/m	−103.70% (below 0%: shrinking)	37.35%	(19.37%)
FOXX Foxx Development Holdings Inc.	$17.3M	— (loss-making)	—	−49.92% (below 0%: shrinking)	n/m	+11.09% (above 0%: growing)	(26.08%)	(97.68%)	Compare
MSN Emerson Radio Corporation	$7.4M	— (loss-making)	21.5×	−37.07% (below 0%: shrinking)	n/m	−66.15% (below 0%: shrinking)	49.34%	(65.09%)	Compare
WLDS Wearable Devices Ltd.	$3.1M	— (loss-making)	—	−88.79% (below 0%: shrinking)	n/m	−9.83% (below 0%: shrinking)	(116.67%)	0.00%	Compare
Median of peers	$36.5M	—	—	−28.13%	—	−16.33%	32.77%	(18.57%)

All 19 Consumer Electronics stocks →

Zepp Health Corporation Sponsored ADR (ZEPP) key facts

Strength: Zepp Health Corporation Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $258.9 million, up 41.8% from fiscal 2024.
Zepp Health Corporation Sponsored ADR (ZEPP) is a Consumer Electronics company in the Technology sector, traded in the US as an ADR.
As of October 16, 2026, ZEPP traded at $3.04, a market capitalization of $27.1 million.
Return on equity was −17.2% and debt-to-equity 0.72.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 1.01 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.